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Coexistence of Congenital Syphilis and Cytomegalovi-
rus Infection: A Case Report 
A 22-year-old pregnant woman with an intrave-
nous drug abuse habit delivered a girl in the 26th 
gestational week with a fetal length and weight of 
38 cm/990 g (pc. 75-91). She did not participate in 
prenatal care that included screening for congenital 
diseases, syphilis, and human immunodeficiency vi-
rus (HIV) infection during the pregnancy. Laboratory 
examinations revealed positive rapid plasma reagin 
(RPR) (1:128), Treponema pallidum particle agglutina-
tion assay (TPPA) and TpELISA results. Immediately 
before delivery, labial herpes simplex virus-1 (HSV-1), 
Streptococcus agalactiae, and genital yeast infections 
were detected. Hepatitis B surface antigen (HbsAG), 
HIV, and hepatitis C virus (HCV) serology remained 
negative.
The preterm and immature newborn girl had mild 
jaundice, minimal edema, and gluteal hematomas 
with petechiae. The liver and spleen were extremely 
enlarged (reaching the plevic bones). Increased mus-
cle tone and rigid elbow, knee, and hip joints were 
found (Figures 1, 2). Additionally, X-ray examination 
detected multiple jejunal atresia. Brainstem evoked 
response audiometry ruled out hearing loss.
In laboratory investigations anisocytosis, throm-
bocytopenia, elevated liver enzymes (ASAT: 3850 U/L, 
ALAT: 558 U/L, GGT: 292 U/L, ALP: 436 U/L), elevated 
lactate dehydrogenase (LDH) (38180 mmol/L), and 
creatinine kinase (CK) (7.1 U/L) with elevated bilirubin 
levels (87.9 μmol/L) were found.
In microbiology investigations a high CMV virus 
number was detected using a quantitative real-time 
polymerase chain reaction (PCR) method from the 
urine and blood. Syphilis serology was positive (RPR: 
1:16 positive, TPPA, TpELISA, and T. pallidum IgM im-
munoblot positive). HSV PCR (in the oral mucosa, 
conjunctiva, and blood) remained negative.
Figure 1. Extreme hepatosplenomegaly and wrin-
kled, greyish skin.
Figure 2. Maculopapules on the sole.
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Intravenous penicillin-G (100.000 IU/kg/dose 
for 10 days) therapy was administered. Intravenous 
ganciclovir was started, but was discontinued after 
2 weeks because of progressive thrombocytopenia 
and elevating liver enzymes. The newborn under-
went transfusion due to anemia and extreme throm-
bocytopenia. Blue light therapy was administered 
for 3 days because of jaundice. The multiple jejunal 
atresia was treated by operation (terminoterminal 
jejuno-jejunostomia and ileal stricturaplastica) in the 
Semmelweis University Pediatrics Clinic. 
At the time of writing this report, the girl was 2 
months old, growing and developing; her intestinal 
passage is satisfactory, but the liver enzymes are ex-
tremely high due to the CMV infection.
Congenital syphilis and congenital CMV are pre-
ventable diseases, but they are still the most common 
causes of perinatal mortality and morbidity world-
wide (4,5). 
Intravenous drug users and mothers of low socio-
economic status belong to the highest risk groups for 
vertical transmission of infections.
Congenital syphilis may induce jaundice, hepa-
tosplenomegaly, wrinkled skin, thrombocytopenia, 
and anemia, with symptoms that are clinically similar 
to congenital CMV infection, making the differential 
diagnosis difficult (1,5,6). Although syphilis screening 
tests are mandatory in the first trimester of pregnancy 
in Hungary, at least one congenital syphilis case was 
observed yearly since the mid-nineties. Therefore, a 
second syphilis test is strongly recommended after 
the 28th gestational week or before delivery, particu-
larly in high risk groups (7). 
The prenatal diagnosis of fetal CMV infection is 
based on amniocentesis in the 21st gestational week, 
which is a risky and non-standard method. The widely 
used ultrasonography examination often yields a un-
certain diagnosis (8).
Intravenous penicilline-G is effective treatment 
for congenital syphilis, but there is no gold standard 
therapy for CMV infection. Treatment with ganciclovir 
may prevent hearing loss later in life, but it has sever-
al severe side effects (neutropenia, anemia, thrombo-
cytopenia, elevated liver enzymes) (9). Furthermore, 
studies on the effect of prolonged valganciclovir 
therapy are still ongoing (10). Prevention is the most 
effective method of reducing the prevalence of con-
genital CMV: pregnant women should avoid contact 
with the saliva of young children. 
In our case, the mother of the newborn belonged 
to a high risk group and did not participate in the pre-
natal caring system; mandatory screening tests were 
not done, so congenital infections were diagnosed 
only at delivery. The treatment for congenital syphilis 
was effective, and resulted in decrease of RPR titers. 
Most of the clinical symptoms did not improve, and 
the liver enzymes were continuously increased, indi-
cating that CMV infection was a major contributor in 
clinical manifestation. Further follow up is needed to 
evaluate the radiological findings of long bones.
Our case draws attention to the importance of 
early and effective prenatal diagnosis, adequate 
treatment of prenatal infectious diseases, and the ne-
cessity of a multidisciplinary approach to congenital 
infections. 
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